海外の治験の状況「前立腺癌」での検索結果
266件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
- Prostate Cancer;Castration-resistant Prostate Cancer;Metastatic Prostate Cancer
- Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, France, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, United Kingdom
- 2014-02-18
Not recruiting
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
- Hormone Sensitive Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Australia, Austria, Brazil, Canada, Denmark, Finland, France, Italy, Korea, Republic of, Netherlands, Poland, Slovakia, Spain, Sweden, Taiwan, United Kingdom, United States
- 2014-12-14
Not recruiting
- Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- South Africa
- 2012-07-31
Not recruiting
- Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Australia, Austria, Belgium, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Poland, Spain, United Kingdom, United States
- 2008-03-13
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, France, Germany, Hungary, India, Italy, Korea, Republic of, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2008-01-24
Not recruiting
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Finland, Former Serbia and Montenegro, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2008-01-24
Not recruiting
- A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia
- 2009-01-14
Not recruiting
- Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Czech Republic, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2010-08-31
Not recruiting
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, Belgium, Canada, Czech Republic, Estonia, Finland, France, Greece, Hungary, Italy, Netherlands, Poland, Spain, United States
- 2010-08-31
Not recruiting
- Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
- Prostatic Neoplasm;Prostatic Neoplasm;Prostatic Neoplasm;Prostatic Neoplasm
- South Africa
- 2008-09-11